M&A Deal Summary

CONMED Acquires Linvatec

On November 26, 1997, CONMED acquired medical products company Linvatec from Bristol-Myers Squibb for 370M USD

Acquisition Highlights
  • This is CONMED’s 1st transaction in the Medical Products sector.
  • This is CONMED’s largest (disclosed) transaction.
  • This is CONMED’s 1st transaction in the United States.
  • This is CONMED’s 1st transaction in Florida.

M&A Deal Summary
Date 1997-11-26
Target Linvatec
Sector Medical Products
Buyer(s) CONMED
Sellers(s) Bristol-Myers Squibb
Deal Type Divestiture
Deal Value 370M USD

Target

Linvatec

Largo, Florida, United States
Linvatec is a provider of medical surgical device company specializing in the design, manufacture and worldwide distribution of arthroscopy products and powered instruments.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CONMED

Largo, Florida, United States

website

Category Company
Founded 1970
Sector Medical Products
Employees4,100
Revenue 1.0B USD (2022)
DESCRIPTION

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. CONMED was founded in 1970 and is based in Largo, Florida.

DEAL STATS #
Overall 1 of 9
Sector (Medical Products) 1 of 9
Type (Divestiture) 1 of 3
State (Florida) 1 of 1
Country (United States) 1 of 8
Year (1997) 1 of 1
Size (of disclosed) 1 of 7
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-13 Bionx Implants

Blue Bell, Pennsylvania, United States

Bionx Implants, Inc. develops, manufactures and sells bio-absorbable implants for sports medicine surgical procedures.

Buy $48M

Seller(S) 1

SELLER

Bristol-Myers Squibb

New York, New York, United States

website

Category Company
Founded 1887
Sector Life Science
Employees32,200
Revenue 46.2B USD (2022)
DESCRIPTION

Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was incorporated in 1887 and is based in New York City.

DEAL STATS #
Overall 1 of 13
Sector (Medical Products) 1 of 5
Type (Divestiture) 1 of 9
State (Florida) 1 of 1
Country (United States) 1 of 8
Year (1997) 1 of 1
Size (of disclosed) 5 of 6
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2000-04-18 Matrix Essentials

Cleveland, Ohio, United States

Matrix Essentials, Inc. is a manufacturer of haircare products for the professional salon industry in North America.

Sell -
Mergr

Product

Company

Legal